GO Term |
GO Name |
Enriched Genes |
Log10 Adjusted P-value |
[BP] GO:0010035 |
response to inorganic substance
|
AKR1B1, APP, AXL, BCL2, CA2, CYP1A1, CYP1B1, FABP4, KDR, KIT, MMP9, PTGES, RELA, SRC, TERT |
8.25674 |
[BP] GO:0042127 |
regulation of cell proliferation
|
AKR1B1, APP, AR, BCL2, CYP1B1, DNMT1, ESR1, ESRRA, F3, FLT3, GPER1, IGF1R, KDR, KIT, MAP2K1, MMP2, MMP9, PIM1, PTGES, RELA, SRC, TERT, XDH |
7.57343 |
[BP] GO:0030522 |
intracellular receptor signaling pathway
|
AR, ESR1, ESR2, ESRRA, ESRRB, GPER1, MAP3K7, PIM1, RELA, SRC |
6.99168 |
[BP] GO:0010647 |
positive regulation of cell communication
|
AKR1B1, APP, AR, AXL, BCL2, CA2, CA7, CYP19A1, CYP1B1, F3, FLT3, GPER1, KDR, KIT, MAP2K1, MAP3K7, MET, MMP9, RELA, SRC, TERT, XDH |
6.82215 |
[BP] GO:0023056 |
positive regulation of signaling
|
AKR1B1, APP, AR, AXL, BCL2, CA2, CA7, CYP19A1, CYP1B1, F3, FLT3, GPER1, KDR, KIT, MAP2K1, MAP3K7, MET, MMP9, RELA, SRC, TERT, XDH |
6.82215 |
[BP] GO:0070887 |
cellular response to chemical stimulus
|
AKR1B1, ALPL, APP, AR, AXL, BCL2, CYP1A1, CYP1B1, DNMT1, ESR1, FABP4, FLT3, GPER1, IGF1R, KDR, KIT, MMP2, MMP9, RELA, SRC, TERT |
6.82215 |
[BP] GO:0010646 |
regulation of cell communication
|
ACHE, AKR1B1, APP, AR, AURKB, AXL, BACE1, BCL2, CA2, CA7, CACNA1C, CYP19A1, CYP1B1, DYRK1A, ESR1, ESR2, F3, FLT3, GPER1, IGF1R, KDR, KIT, MAP2K1, MAP3K7, MET, MMP9, RELA, SRC, TERT, XDH |
6.77569 |
[BP] GO:0042221 |
response to chemical
|
ABCB1, AKR1B1, ALPL, APP, AR, AXL, BCL2, CA2, CA9, CYP1A1, CYP1B1, DNMT1, ESR1, ESRRA, FABP4, FLT3, GPER1, IGF1R, KDR, KIT, MMP2, MMP9, PTGES, RELA, SRC, TERT |
6.74781 |
[BP] GO:0043067 |
regulation of programmed cell death
|
AKR1B1, AR, AURKB, AXL, BCL2, CYP1B1, ESR1, F3, FLT3, GPER1, IGF1R, KDR, KIT, MAP2K1, MET, MMP9, PIM1, RELA, SRC, TERT, XDH |
6.74781 |
[BP] GO:0023051 |
regulation of signaling
|
ACHE, AKR1B1, APP, AR, AURKB, AXL, BACE1, BCL2, CA2, CA7, CACNA1C, CYP19A1, CYP1B1, DYRK1A, ESR1, ESR2, F3, FLT3, GPER1, IGF1R, KDR, KIT, MAP2K1, MAP3K7, MET, MMP9, RELA, SRC, TERT, XDH |
6.74628 |
[BP] GO:0071310 |
cellular response to organic substance
|
AKR1B1, ALPL, APP, AR, AXL, BCL2, CYP1A1, CYP1B1, DNMT1, ESR1, FABP4, FLT3, GPER1, IGF1R, KDR, KIT, MMP2, RELA, SRC |
6.67595 |
[BP] GO:1902533 |
positive regulation of intracellular signal transduction
|
AKR1B1, APP, AR, AXL, BCL2, CYP1B1, F3, FLT3, GPER1, KDR, KIT, MAP2K1, MAP3K7, MET, RELA, SRC, XDH |
6.39963 |
[BP] GO:1901700 |
response to oxygen-containing compound
|
AKR1B1, ALPL, APP, AR, AXL, BCL2, CA9, CYP1A1, CYP1B1, DNMT1, ESR1, ESRRA, GPER1, IGF1R, MMP2, MMP9, PTGES, RELA, SRC |
6.39963 |
[BP] GO:0010033 |
response to organic substance
|
AKR1B1, ALPL, APP, AR, AXL, BCL2, CA2, CA9, CYP1A1, CYP1B1, DNMT1, ESR1, ESRRA, FABP4, FLT3, GPER1, IGF1R, KDR, KIT, MMP2, PTGES, RELA, SRC |
6.39963 |
[BP] GO:0009719 |
response to endogenous stimulus
|
AKR1B1, ALPL, APP, AR, BCL2, CA2, CA9, DNMT1, ESR1, ESRRA, FLT3, GPER1, IGF1R, KIT, MMP2, RELA, SRC |
6.39963 |
[BP] GO:0051716 |
cellular response to stimulus
|
AKR1B1, ALPL, APP, AR, AURKB, AXL, BCL2, CA2, CA9, CYP1A1, CYP1B1, DNMT1, ESR1, FABP4, FLT3, GPER1, IGF1R, KDR, KIT, MAP2K1, MAP3K7, MMP2, MMP9, RELA, SRC, TERT |
6.39963 |
[BP] GO:1902531 |
regulation of intracellular signal transduction
|
AKR1B1, APP, AR, AURKB, AXL, BCL2, CYP1B1, DYRK1A, ESR1, F3, FLT3, GPER1, IGF1R, KDR, KIT, MAP2K1, MAP3K7, MET, MMP9, RELA, SRC, XDH |
6.39963 |
[BP] GO:0048522 |
positive regulation of cellular process
|
ACHE, AKR1B1, APP, AR, AURKB, AXL, BCL2, CA2, CA7, CYP19A1, CYP1A1, CYP1B1, DNMT1, DYRK1A, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, GPER1, IGF1R, KDR, KIT, MAP2K1, MAP3K7, MET, MMP1, MMP2, MMP9, PIM1, RELA, SRC, TERT, XDH |
6.39963 |
[BP] GO:0010941 |
regulation of cell death
|
AKR1B1, AR, AURKB, AXL, BCL2, CYP1B1, ESR1, F3, FLT3, GPER1, IGF1R, KDR, KIT, MAP2K1, MET, MMP9, PIM1, RELA, SRC, TERT, XDH |
6.39963 |
[BP] GO:0048518 |
positive regulation of biological process
|
ABCB1, ACHE, AKR1B1, APP, AR, AURKB, AXL, BCL2, CA2, CA7, CYP19A1, CYP1A1, CYP1B1, DNMT1, DYRK1A, ESR1, ESR2, ESRRA, ESRRB, F3, FABP4, FLT3, GPER1, IGF1R, KDR, KIT, MAP2K1, MAP3K7, MET, MMP1, MMP2, MMP9, PIM1, RELA, SRC, TERT, XDH |
6.39963 |
[BP] GO:0014070 |
response to organic cyclic compound
|
ALPL, APP, AR, BCL2, CA2, CA9, CYP1A1, CYP1B1, ESR1, ESRRA, FLT3, GPER1, PTGES, RELA, SRC |
6.39963 |
[BP] GO:0048513 |
animal organ development
|
ACHE, AR, AXL, BCL2, CA2, CACNA1C, CYP19A1, CYP1A1, ESR1, ESRRA, ESRRB, FLT3, HSD17B3, KDR, KIT, MAP2K1, RELA, SRC |
6.15924 |
[BP] GO:0008152 |
metabolic process
|
ACHE, AKR1B1, AKR1B10, ALOX5, ALPL, AOX1, APP, AR, AURKB, AXL, BACE1, BCL2, CA12, CA2, CA4, CA7, CA9, CYP19A1, CYP1A1, CYP1B1, DNMT1, DYRK1A, ESR1, ESR2, ESRRA, ESRRB, F3, FABP4, FLT3, FUT7, HSD17B3, IGF1R, KDR, KIT, MAOA, MAP2K1, MAP3K7, MET, MMP1, MMP2, MMP9, PIM1, PTGES, RELA, SRC, TERT, XDH |
5.9605 |
[BP] GO:0018108 |
peptidyl-tyrosine phosphorylation
|
AXL, DYRK1A, FLT3, IGF1R, KDR, KIT, MAP2K1, MET, SRC |
5.94549 |
[BP] GO:0044237 |
cellular metabolic process
|
ACHE, AKR1B1, AKR1B10, ALOX5, ALPL, AOX1, APP, AR, AURKB, AXL, BACE1, BCL2, CA12, CA2, CA4, CA7, CA9, CYP19A1, CYP1A1, CYP1B1, DNMT1, DYRK1A, ESR1, ESR2, ESRRA, ESRRB, FABP4, FLT3, FUT7, HSD17B3, IGF1R, KDR, KIT, MAOA, MAP2K1, MAP3K7, MET, MMP1, MMP2, PIM1, PTGES, RELA, SRC, TERT, XDH |
5.92591 |
[BP] GO:0018212 |
peptidyl-tyrosine modification
|
AXL, DYRK1A, FLT3, IGF1R, KDR, KIT, MAP2K1, MET, SRC |
5.91317 |
[BP] GO:0015701 |
bicarbonate transport
|
CA12, CA14, CA2, CA4, CA7, CA9 |
5.90127 |
[BP] GO:0065008 |
regulation of biological quality
|
ABCB1, ACHE, AKR1B1, APP, AR, AURKB, AXL, BCL2, CA12, CA2, CA7, CACNA1C, CYP19A1, CYP1A1, CYP1B1, ESR1, F3, FABP4, FLT3, GPER1, HSD17B3, KDR, KIT, MAOA, MET, SRC, TERT, XDH |
5.78038 |
[BP] GO:0033993 |
response to lipid
|
ALPL, AR, AXL, BCL2, CA2, CA9, CYP1A1, ESR1, ESRRA, FLT3, GPER1, PTGES, RELA, SRC |
5.59248 |
[BP] GO:0042981 |
regulation of apoptotic process
|
AKR1B1, AR, AURKB, AXL, BCL2, CYP1B1, ESR1, F3, FLT3, GPER1, IGF1R, KDR, MAP2K1, MMP9, PIM1, RELA, SRC, TERT, XDH |
5.5307 |
[BP] GO:0009967 |
positive regulation of signal transduction
|
AKR1B1, APP, AR, AXL, BCL2, CYP1B1, F3, FLT3, GPER1, KDR, KIT, MAP2K1, MAP3K7, MET, MMP9, RELA, SRC, TERT, XDH |
5.49943 |
[BP] GO:0008284 |
positive regulation of cell proliferation
|
AKR1B1, AR, BCL2, ESR1, F3, FLT3, GPER1, IGF1R, KDR, KIT, MMP2, MMP9, PIM1, RELA, TERT |
5.42764 |
[BP] GO:0051240 |
positive regulation of multicellular organismal process
|
APP, AR, AXL, BCL2, CA2, CYP1B1, ESRRB, F3, GPER1, KDR, KIT, MAP2K1, MAP3K7, MET, MMP9, PIM1, RELA, SRC, TERT |
5.42764 |
[BP] GO:0048584 |
positive regulation of response to stimulus
|
AKR1B1, APP, AR, AXL, BCL2, CYP1B1, ESRRA, F3, FABP4, FLT3, GPER1, KDR, KIT, MAP2K1, MAP3K7, MET, MMP2, MMP9, RELA, SRC, TERT, XDH |
5.23181 |
[BP] GO:0008283 |
cell proliferation
|
ABCB1, ACHE, AR, AURKB, BCL2, CYP1A1, ESR1, FLT3, KIT, MAP2K1, MET, PIM1, SRC |
5.19862 |
[BP] GO:0009725 |
response to hormone
|
AKR1B1, ALPL, AR, BCL2, CA2, CA9, ESR1, ESRRA, FLT3, GPER1, KIT, RELA, SRC |
5.16902 |
[BP] GO:0030335 |
positive regulation of cell migration
|
APP, BCL2, F3, GPER1, IGF1R, KDR, KIT, MET, MMP9, SRC, TERT |
5.04527 |
[BP] GO:0032502 |
developmental process
|
ACHE, AKR1B1, ALPL, APP, AR, AURKB, AXL, BCL2, CA2, CA9, CACNA1C, CYP19A1, CYP1A1, CYP1B1, DYRK1A, ESR1, ESRRA, ESRRB, FABP4, FLT3, FUT7, HSD17B3, KDR, KIT, MAP2K1, MET, MMP2, MMP9, PIM1, RELA, SRC, TERT |
5.04057 |
[BP] GO:2000147 |
positive regulation of cell motility
|
APP, BCL2, F3, GPER1, IGF1R, KDR, KIT, MET, MMP9, SRC, TERT |
4.90502 |
[BP] GO:0048608 |
reproductive structure development
|
AR, AXL, BCL2, CYP19A1, ESR1, HSD17B3, KIT, MAP2K1, SRC |
4.79748 |
[BP] GO:0051272 |
positive regulation of cellular component movement
|
APP, BCL2, F3, GPER1, IGF1R, KDR, KIT, MET, MMP9, SRC, TERT |
4.79741 |
[BP] GO:0051130 |
positive regulation of cellular component organization
|
APP, AR, AURKB, AXL, BCL2, DNMT1, ESR1, GPER1, IGF1R, KDR, KIT, MAP2K1, MET, MMP1, MMP9, SRC |
4.79661 |
[BP] GO:0006730 |
one-carbon metabolic process
|
CA12, CA2, CA4, CA7, CA9 |
4.79661 |
[BP] GO:0048583 |
regulation of response to stimulus
|
ABCB1, AKR1B1, APP, AR, AURKB, AXL, BCL2, CYP19A1, CYP1B1, DYRK1A, ESR1, ESR2, ESRRA, F3, FABP4, FLT3, GPER1, IGF1R, KDR, KIT, MAP2K1, MAP3K7, MET, MMP2, MMP9, RELA, SRC, TERT, XDH |
4.77363 |
[BP] GO:0043069 |
negative regulation of programmed cell death
|
AKR1B1, AR, AURKB, AXL, BCL2, IGF1R, KDR, KIT, MET, MMP9, PIM1, RELA, SRC, TERT |
4.76029 |
[BP] GO:0046777 |
protein autophosphorylation
|
AURKB, DYRK1A, FLT3, IGF1R, KDR, KIT, PIM1, SRC |
4.74105 |
[BP] GO:0043401 |
steroid hormone mediated signaling pathway
|
AR, ESR1, ESR2, ESRRA, ESRRB, GPER1, SRC |
4.70779 |
[BP] GO:0044093 |
positive regulation of molecular function
|
ABCB1, APP, AR, AURKB, BCL2, ESR1, ESR2, F3, FLT3, GPER1, KIT, MAP2K1, MAP3K7, MET, MMP9, RELA, SRC, TERT, XDH |
4.70779 |
[BP] GO:0040017 |
positive regulation of locomotion
|
APP, BCL2, F3, GPER1, IGF1R, KDR, KIT, MET, MMP9, SRC, TERT |
4.70779 |
[BP] GO:0051270 |
regulation of cellular component movement
|
APP, BCL2, CACNA1C, CYP19A1, CYP1B1, F3, GPER1, IGF1R, KDR, KIT, MET, MMP9, SRC, TERT |
4.65711 |
[BP] GO:1901701 |
cellular response to oxygen-containing compound
|
AKR1B1, APP, AR, AXL, CYP1B1, DNMT1, ESR1, GPER1, IGF1R, MMP2, MMP9, RELA, SRC |
4.64611 |
[BP] GO:0032847 |
regulation of cellular pH reduction
|
BCL2, CA2, CA7 |
4.62846 |
[BP] GO:0030334 |
regulation of cell migration
|
APP, BCL2, CYP19A1, CYP1B1, F3, GPER1, IGF1R, KDR, KIT, MET, MMP9, SRC, TERT |
4.53339 |
[BP] GO:0051094 |
positive regulation of developmental process
|
APP, AR, AXL, BCL2, CA2, CYP1B1, ESRRB, F3, GPER1, KDR, KIT, MAP2K1, PIM1, RELA, SRC, TERT |
4.45437 |
[BP] GO:0051173 |
positive regulation of nitrogen compound metabolic process
|
APP, AR, AURKB, BCL2, DNMT1, DYRK1A, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, GPER1, IGF1R, KDR, KIT, MAP2K1, MAP3K7, MET, MMP9, RELA, SRC, TERT, XDH |
4.45437 |
[BP] GO:0006468 |
protein phosphorylation
|
APP, AURKB, AXL, BCL2, DYRK1A, FLT3, IGF1R, KDR, KIT, MAP2K1, MAP3K7, MET, PIM1, SRC |
4.45437 |
[BP] GO:0048545 |
response to steroid hormone
|
ALPL, AR, BCL2, CA2, FLT3, GPER1, RELA, SRC |
4.45437 |
[BP] GO:0080134 |
regulation of response to stress
|
ABCB1, APP, CYP19A1, DYRK1A, ESR1, F3, FABP4, GPER1, IGF1R, MAP2K1, MAP3K7, MET, MMP2, RELA, SRC, TERT, XDH |
4.38898 |
[BP] GO:0060548 |
negative regulation of cell death
|
AKR1B1, AR, AURKB, AXL, BCL2, IGF1R, KDR, KIT, MET, MMP9, PIM1, RELA, SRC, TERT |
4.38898 |
[BP] GO:0048856 |
anatomical structure development
|
ACHE, AKR1B1, ALPL, APP, AR, AXL, BCL2, CA2, CACNA1C, CYP19A1, CYP1A1, CYP1B1, DYRK1A, ESR1, ESRRA, ESRRB, FLT3, HSD17B3, KDR, KIT, MAP2K1, MMP9, PIM1, RELA, SRC |
4.38121 |
[BP] GO:0010038 |
response to metal ion
|
APP, BCL2, CA2, CYP1A1, FABP4, KIT, MMP9, PTGES, TERT |
4.3474 |
[BP] GO:2000145 |
regulation of cell motility
|
APP, BCL2, CYP19A1, CYP1B1, F3, GPER1, IGF1R, KDR, KIT, MET, MMP9, SRC, TERT |
4.27748 |
[BP] GO:0071495 |
cellular response to endogenous stimulus
|
AKR1B1, APP, AR, DNMT1, ESR1, FLT3, GPER1, IGF1R, KIT, MMP2, RELA, SRC |
4.27243 |
[BP] GO:0031325 |
positive regulation of cellular metabolic process
|
APP, AR, AURKB, BCL2, DNMT1, DYRK1A, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, GPER1, IGF1R, KDR, KIT, MAP2K1, MAP3K7, MET, MMP9, RELA, SRC, TERT, XDH |
4.20022 |
[BP] GO:0019748 |
secondary metabolic process
|
AKR1B1, AKR1B10, BCL2, CYP1A1, CYP1B1 |
4.18615 |
[BP] GO:0044281 |
small molecule metabolic process
|
AKR1B1, AKR1B10, ALOX5, AOX1, APP, CA12, CA2, CA4, CA7, CA9, CYP19A1, CYP1A1, CYP1B1, FUT7, HSD17B3, PIM1, PTGES, XDH |
4.18556 |
[BP] GO:0010604 |
positive regulation of macromolecule metabolic process
|
APP, AR, AURKB, BCL2, DNMT1, DYRK1A, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, GPER1, IGF1R, KDR, KIT, MAP2K1, MAP3K7, MET, MMP9, RELA, SRC, TERT, XDH |
4.17233 |
[BP] GO:0008202 |
steroid metabolic process
|
AKR1B1, AKR1B10, APP, CYP19A1, CYP1A1, CYP1B1, ESR1, HSD17B3 |
4.12586 |
[BP] GO:0022414 |
reproductive process
|
AKR1B1, ALPL, APP, AR, AXL, BCL2, CYP19A1, CYP1A1, ESR1, ESRRB, HSD17B3, KIT, MAP2K1, MMP2, MMP9, SRC |
4.12226 |
[BP] GO:0009755 |
hormone-mediated signaling pathway
|
AR, ESR1, ESR2, ESRRA, ESRRB, GPER1, SRC |
4.12226 |
[BP] GO:0009966 |
regulation of signal transduction
|
AKR1B1, APP, AR, AURKB, AXL, BCL2, CYP1B1, DYRK1A, ESR1, ESR2, F3, FLT3, GPER1, IGF1R, KDR, KIT, MAP2K1, MAP3K7, MET, MMP9, RELA, SRC, TERT, XDH |
4.12226 |
[BP] GO:0051239 |
regulation of multicellular organismal process
|
APP, AR, AXL, BCL2, CA2, CACNA1C, CYP1B1, ESR1, ESRRA, ESRRB, F3, GPER1, KDR, KIT, MAP2K1, MAP3K7, MET, MMP9, PIM1, RELA, SRC, TERT, XDH |
4.06969 |
[BP] GO:0071407 |
cellular response to organic cyclic compound
|
ALPL, APP, AR, CYP1A1, CYP1B1, ESR1, FLT3, GPER1, SRC |
4.06427 |
[BP] GO:0000302 |
response to reactive oxygen species
|
AKR1B1, AXL, BCL2, CYP1B1, MMP9, RELA, SRC |
4.01864 |
[BP] GO:0006629 |
lipid metabolic process
|
ACHE, AKR1B1, AKR1B10, ALOX5, APP, CYP19A1, CYP1A1, CYP1B1, ESR1, FABP4, FUT7, HSD17B3, KIT, MET, PTGES |
4.01864 |
[BP] GO:0042542 |
response to hydrogen peroxide
|
AKR1B1, AXL, BCL2, CYP1B1, RELA, SRC |
4.00211 |
[BP] GO:0034754 |
cellular hormone metabolic process
|
AKR1B1, CYP19A1, CYP1A1, CYP1B1, ESR1, HSD17B3 |
4.00211 |
[BP] GO:0034614 |
cellular response to reactive oxygen species
|
AKR1B1, AXL, CYP1B1, MMP9, RELA, SRC |
4.00211 |
[BP] GO:0003006 |
developmental process involved in reproduction
|
ALPL, AR, AXL, BCL2, CYP19A1, ESR1, ESRRB, HSD17B3, KIT, MAP2K1, SRC |
3.99539 |
[BP] GO:0040012 |
regulation of locomotion
|
APP, BCL2, CYP19A1, CYP1B1, F3, GPER1, IGF1R, KDR, KIT, MET, MMP9, SRC, TERT |
3.97256 |
[BP] GO:0051247 |
positive regulation of protein metabolic process
|
APP, AR, BCL2, DNMT1, DYRK1A, ESR1, F3, FLT3, GPER1, KDR, KIT, MAP2K1, MAP3K7, MMP9, RELA, SRC, XDH |
3.87857 |
[BP] GO:0032501 |
multicellular organismal process
|
AKR1B1, AKR1B10, ALOX5, ALPL, APP, AR, AXL, BCL2, CACNA1C, CYP19A1, CYP1B1, ESR1, ESRRB, F3, FABP4, GPER1, IGF1R, KIT, MET, MMP1, MMP2, MMP9, PIM1, RELA, SRC |
3.87857 |
[BP] GO:0042445 |
hormone metabolic process
|
ACHE, AKR1B1, CYP19A1, CYP1A1, CYP1B1, ESR1, HSD17B3 |
3.87857 |
[BP] GO:0048523 |
negative regulation of cellular process
|
ACHE, AKR1B1, APP, AR, AURKB, AXL, BCL2, CYP19A1, CYP1B1, DNMT1, DYRK1A, ESR1, ESR2, ESRRA, ESRRB, FABP4, GPER1, IGF1R, KDR, KIT, MAP2K1, MET, MMP9, PIM1, PTGES, RELA, SRC, TERT, XDH |
3.86504 |
[BP] GO:0051090 |
regulation of DNA binding transcription factor activity
|
APP, AR, CYP1B1, ESR1, ESR2, KIT, MAP3K7, PIM1, RELA |
3.75876 |
[BP] GO:0043410 |
positive regulation of MAPK cascade
|
APP, AR, FLT3, GPER1, KDR, KIT, MAP2K1, MAP3K7, SRC, XDH |
3.73457 |
[BP] GO:1902532 |
negative regulation of intracellular signal transduction
|
BCL2, DYRK1A, ESR1, GPER1, IGF1R, MET, MMP9, RELA, SRC, XDH |
3.69273 |
[BP] GO:0009893 |
positive regulation of metabolic process
|
APP, AR, AURKB, BCL2, DNMT1, DYRK1A, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, GPER1, IGF1R, KDR, KIT, MAP2K1, MAP3K7, MET, MMP9, RELA, SRC, TERT, XDH |
3.68649 |
[BP] GO:0009636 |
response to toxic substance
|
AKR1B1, ALPL, AXL, BCL2, CYP1A1, CYP1B1, KDR, RELA, SRC |
3.65547 |
[BP] GO:2000026 |
regulation of multicellular organismal development
|
APP, AR, AXL, BCL2, CA2, CYP1B1, ESR1, ESRRA, F3, GPER1, KDR, KIT, MAP2K1, PIM1, RELA, SRC, TERT, XDH |
3.64598 |
[BP] GO:0035265 |
organ growth
|
AR, BCL2, CYP19A1, ESR1 |
3.6281 |
[BP] GO:0043393 |
regulation of protein binding
|
APP, AURKB, BCL2, MET, MMP9, SRC, TERT |
3.6281 |
[BP] GO:2000021 |
regulation of ion homeostasis
|
BCL2, CA2, CA7, CACNA1C, GPER1, KDR, SRC |
3.58977 |
[BP] GO:1901615 |
organic hydroxy compound metabolic process
|
AKR1B1, AKR1B10, APP, BCL2, CYP19A1, CYP1A1, CYP1B1, HSD17B3, MAOA |
3.56923 |
[BP] GO:0016310 |
phosphorylation
|
APP, AURKB, AXL, BCL2, DYRK1A, FLT3, IGF1R, KDR, KIT, MAP2K1, MAP3K7, MET, PIM1, SRC |
3.56574 |
[BP] GO:0051896 |
regulation of protein kinase B signaling
|
AXL, F3, GPER1, KIT, MET, SRC, XDH |
3.56324 |
[BP] GO:0032270 |
positive regulation of cellular protein metabolic process
|
APP, AR, BCL2, DNMT1, DYRK1A, ESR1, F3, FLT3, GPER1, KDR, KIT, MAP2K1, MAP3K7, MMP9, SRC, XDH |
3.54805 |
[BP] GO:0042327 |
positive regulation of phosphorylation
|
APP, AR, BCL2, ESRRB, FLT3, GPER1, KDR, KIT, MAP2K1, MAP3K7, MMP9, SRC, XDH |
3.54673 |
[BP] GO:0032879 |
regulation of localization
|
ABCB1, ACHE, APP, AR, AXL, BCL2, CA2, CA7, CACNA1C, CYP19A1, CYP1B1, F3, GPER1, IGF1R, KDR, KIT, MAP2K1, MET, MMP9, SRC, TERT |
3.50664 |
[BP] GO:0044238 |
primary metabolic process
|
ACHE, AKR1B1, AKR1B10, ALOX5, ALPL, AOX1, APP, AR, AURKB, AXL, BACE1, BCL2, CYP19A1, CYP1A1, CYP1B1, DNMT1, DYRK1A, ESR1, ESR2, ESRRA, ESRRB, F3, FABP4, FLT3, FUT7, HSD17B3, IGF1R, KDR, KIT, MAP2K1, MAP3K7, MET, MMP1, MMP2, MMP9, PIM1, PTGES, RELA, SRC, TERT, XDH |
3.48256 |
[BP] GO:0042592 |
homeostatic process
|
AKR1B1, APP, AXL, BCL2, CA12, CA2, CA7, CACNA1C, ESR1, FABP4, FLT3, GPER1, MET, SRC, TERT |
3.48213 |
[BP] GO:0071704 |
organic substance metabolic process
|
ACHE, AKR1B1, AKR1B10, ALOX5, ALPL, AOX1, APP, AR, AURKB, AXL, BACE1, BCL2, CYP19A1, CYP1A1, CYP1B1, DNMT1, DYRK1A, ESR1, ESR2, ESRRA, ESRRB, F3, FABP4, FLT3, FUT7, HSD17B3, IGF1R, KDR, KIT, MAOA, MAP2K1, MAP3K7, MET, MMP1, MMP2, MMP9, PIM1, PTGES, RELA, SRC, TERT, XDH |
3.46319 |
[BP] GO:0031399 |
regulation of protein modification process
|
APP, AR, BCL2, DNMT1, DYRK1A, FABP4, FLT3, GPER1, IGF1R, KDR, KIT, MAP2K1, MAP3K7, MMP9, RELA, SRC, XDH |
3.44105 |
[BP] GO:0030518 |
intracellular steroid hormone receptor signaling pathway
|
AR, ESR1, ESR2, GPER1, SRC |
3.44105 |
[BP] GO:0043066 |
negative regulation of apoptotic process
|
AKR1B1, AR, AURKB, AXL, BCL2, IGF1R, KDR, MMP9, PIM1, RELA, SRC, TERT |
3.43529 |
[BP] GO:2001225 |
regulation of chloride transport
|
ABCB1, CA2, CA7 |
3.43438 |
[BP] GO:0050896 |
response to stimulus
|
ABCB1, ACHE, AKR1B1, ALPL, APP, AR, AURKB, AXL, BCL2, CA2, CA9, CYP1A1, CYP1B1, DNMT1, ESR1, ESRRA, F3, FABP4, FLT3, GPER1, IGF1R, KDR, KIT, MAP2K1, MAP3K7, MMP2, MMP9, PTGES, RELA, SRC, TERT |
3.40436 |
[BP] GO:0031401 |
positive regulation of protein modification process
|
APP, AR, BCL2, DNMT1, DYRK1A, FLT3, GPER1, KDR, KIT, MAP2K1, MAP3K7, MMP9, SRC, XDH |
3.37948 |
[BP] GO:0043408 |
regulation of MAPK cascade
|
APP, AR, FLT3, GPER1, IGF1R, KDR, KIT, MAP2K1, MAP3K7, SRC, XDH |
3.36433 |
[BP] GO:0018193 |
peptidyl-amino acid modification
|
AURKB, AXL, BCL2, DYRK1A, FLT3, IGF1R, KDR, KIT, MAP2K1, MAP3K7, MET, SRC |
3.33599 |
[BP] GO:0002320 |
lymphoid progenitor cell differentiation
|
BCL2, FLT3, KIT |
3.31985 |
[BP] GO:0060736 |
prostate gland growth
|
AR, CYP19A1, ESR1 |
3.31985 |
[BP] GO:0048806 |
genitalia development
|
AXL, CYP19A1, ESR1, HSD17B3 |
3.29191 |
[BP] GO:0006979 |
response to oxidative stress
|
AKR1B1, APP, AXL, BCL2, CYP1B1, MMP9, RELA, SRC |
3.26459 |
[BP] GO:1904705 |
regulation of vascular smooth muscle cell proliferation
|
GPER1, MMP2, MMP9, TERT |
3.25406 |
[BP] GO:2001236 |
regulation of extrinsic apoptotic signaling pathway
|
AR, BCL2, GPER1, RELA, SRC, TERT |
3.2505 |
[BP] GO:0051091 |
positive regulation of DNA binding transcription factor activity
|
APP, AR, ESR1, ESR2, KIT, MAP3K7, RELA |
3.23702 |
[BP] GO:1901564 |
organonitrogen compound metabolic process
|
ACHE, AKR1B1, ALPL, AOX1, APP, AR, AURKB, AXL, BACE1, BCL2, CYP1A1, DYRK1A, ESR1, F3, FLT3, FUT7, IGF1R, KDR, KIT, MAOA, MAP2K1, MAP3K7, MET, MMP1, MMP2, MMP9, PIM1, RELA, SRC, XDH |
3.13448 |
[BP] GO:0010648 |
negative regulation of cell communication
|
ACHE, AR, BCL2, DYRK1A, ESR1, ESR2, GPER1, IGF1R, MET, MMP9, RELA, SRC, TERT, XDH |
3.12398 |
[BP] GO:0010562 |
positive regulation of phosphorus metabolic process
|
APP, AR, BCL2, ESRRB, FLT3, GPER1, KDR, KIT, MAP2K1, MAP3K7, MMP9, SRC, XDH |
3.12398 |
[BP] GO:0045937 |
positive regulation of phosphate metabolic process
|
APP, AR, BCL2, ESRRB, FLT3, GPER1, KDR, KIT, MAP2K1, MAP3K7, MMP9, SRC, XDH |
3.12398 |
[BP] GO:0023057 |
negative regulation of signaling
|
ACHE, AR, BCL2, DYRK1A, ESR1, ESR2, GPER1, IGF1R, MET, MMP9, RELA, SRC, TERT, XDH |
3.11532 |
[BP] GO:0065009 |
regulation of molecular function
|
ABCB1, APP, AR, AURKB, BCL2, CYP1B1, ESR1, ESR2, F3, FABP4, FLT3, GPER1, IGF1R, KIT, MAP2K1, MAP3K7, MET, MMP9, PIM1, RELA, SRC, TERT, XDH |
3.06232 |
[BP] GO:0001934 |
positive regulation of protein phosphorylation
|
APP, AR, BCL2, FLT3, GPER1, KDR, KIT, MAP2K1, MAP3K7, MMP9, SRC, XDH |
3.05984 |
[BP] GO:0042325 |
regulation of phosphorylation
|
APP, AR, BCL2, ESRRB, FABP4, FLT3, GPER1, IGF1R, KDR, KIT, MAP2K1, MAP3K7, MMP9, SRC, XDH |
3.04481 |
[BP] GO:0007169 |
transmembrane receptor protein tyrosine kinase signaling pathway
|
AXL, FLT3, IGF1R, KDR, KIT, MET, MMP2, MMP9, SRC |
3.04108 |
[BP] GO:0060065 |
uterus development
|
CYP19A1, ESR1, SRC |
3.04108 |
[BP] GO:0009115 |
None
|
AOX1, XDH |
3.01168 |
[BP] GO:1904018 |
positive regulation of vasculature development
|
CYP1B1, F3, GPER1, KDR, KIT, TERT |
3.00201 |
[BP] GO:0048869 |
cellular developmental process
|
ACHE, ALPL, APP, AR, AXL, BCL2, CYP1A1, ESR1, ESRRB, FABP4, FLT3, FUT7, KDR, KIT, MAP2K1, MET, MMP2, MMP9, SRC, TERT |
2.99552 |
[BP] GO:0010817 |
regulation of hormone levels
|
ACHE, AKR1B1, CACNA1C, CYP19A1, CYP1A1, CYP1B1, ESR1, GPER1, HSD17B3 |
2.98717 |
[BP] GO:0035556 |
intracellular signal transduction
|
AKR1B1, AXL, BCL2, CACNA1C, CYP1B1, DNMT1, GPER1, IGF1R, KDR, KIT, MAP2K1, MAP3K7, MET, RELA, SRC |
2.98672 |
[BP] GO:0048519 |
negative regulation of biological process
|
ACHE, AKR1B1, APP, AR, AURKB, AXL, BCL2, CYP19A1, CYP1B1, DNMT1, DYRK1A, ESR1, ESR2, ESRRA, ESRRB, FABP4, GPER1, IGF1R, KDR, KIT, MAP2K1, MET, MMP9, PIM1, PTGES, RELA, SRC, TERT, XDH |
2.95931 |
[BP] GO:2001237 |
negative regulation of extrinsic apoptotic signaling pathway
|
AR, BCL2, RELA, SRC, TERT |
2.95904 |
[BP] GO:0006796 |
phosphate-containing compound metabolic process
|
ACHE, ALPL, APP, AURKB, AXL, BCL2, DYRK1A, FLT3, IGF1R, KDR, KIT, MAP2K1, MAP3K7, MET, PIM1, SRC, XDH |
2.95847 |
[BP] GO:0071417 |
cellular response to organonitrogen compound
|
AKR1B1, APP, DNMT1, GPER1, IGF1R, MMP2, RELA, SRC |
2.89784 |
[BP] GO:0050793 |
regulation of developmental process
|
APP, AR, AXL, BCL2, CA2, CYP1B1, ESR1, ESRRA, ESRRB, F3, GPER1, KDR, KIT, MAP2K1, PIM1, RELA, SRC, TERT, XDH |
2.89527 |
[BP] GO:0002009 |
morphogenesis of an epithelium
|
AR, BCL2, CA2, CA9, ESR1, MET, SRC |
2.89527 |
[BP] GO:0030540 |
female genitalia development
|
AXL, CYP19A1, ESR1 |
2.89527 |
[BP] GO:0070920 |
None
|
ESR1, MAP2K1, TERT |
2.89527 |
[BP] GO:0007167 |
enzyme linked receptor protein signaling pathway
|
AXL, FLT3, IGF1R, KDR, KIT, MAP3K7, MET, MMP2, MMP9, SRC |
2.8725 |
[BP] GO:0010629 |
None
|
APP, AR, AURKB, DNMT1, DYRK1A, ESR1, ESR2, ESRRA, FABP4, GPER1, KDR, MAP2K1, RELA, SRC, TERT, XDH |
2.87059 |
[BP] GO:0009968 |
negative regulation of signal transduction
|
AR, BCL2, DYRK1A, ESR1, ESR2, GPER1, IGF1R, MET, MMP9, RELA, SRC, TERT, XDH |
2.85587 |
[BP] GO:0001932 |
regulation of protein phosphorylation
|
APP, AR, BCL2, FABP4, FLT3, GPER1, IGF1R, KDR, KIT, MAP2K1, MAP3K7, MMP9, SRC, XDH |
2.84403 |
[BP] GO:0034599 |
cellular response to oxidative stress
|
AKR1B1, AXL, CYP1B1, MMP9, RELA, SRC |
2.79531 |
[BP] GO:0022603 |
regulation of anatomical structure morphogenesis
|
AR, BCL2, CYP1B1, ESR1, F3, KDR, KIT, MAP2K1, PIM1, SRC, TERT, XDH |
2.78924 |
[BP] GO:0007165 |
signal transduction
|
AKR1B1, APP, AR, AXL, BCL2, CA2, CACNA1C, CYP1B1, DNMT1, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, GPER1, IGF1R, KDR, KIT, MAP2K1, MAP3K7, MET, MMP2, MMP9, PIM1, PTGES, RELA, SRC |
2.78511 |
[BP] GO:0050804 |
modulation of chemical synaptic transmission
|
ACHE, APP, BACE1, CA2, CA7, GPER1, KIT |
2.74069 |
[BP] GO:0099177 |
regulation of trans-synaptic signaling
|
ACHE, APP, BACE1, CA2, CA7, GPER1, KIT |
2.74069 |
[BP] GO:0006793 |
phosphorus metabolic process
|
ACHE, ALPL, APP, AURKB, AXL, BCL2, DYRK1A, FLT3, IGF1R, KDR, KIT, MAP2K1, MAP3K7, MET, PIM1, SRC, XDH |
2.7386 |
[BP] GO:0009056 |
catabolic process
|
ACHE, AKR1B10, AOX1, AURKB, BACE1, CYP19A1, CYP1A1, CYP1B1, FABP4, FUT7, MAOA, MMP1, MMP2, MMP9, SRC, XDH |
2.7335 |
[BP] GO:0051900 |
regulation of mitochondrial depolarization
|
BCL2, KDR, SRC |
2.6936 |
[BP] GO:1901699 |
cellular response to nitrogen compound
|
AKR1B1, APP, DNMT1, GPER1, IGF1R, MMP2, RELA, SRC |
2.69282 |
[BP] GO:0097237 |
cellular response to toxic substance
|
AKR1B1, AXL, CYP1B1, KDR, RELA |
2.69282 |
[BP] GO:1901653 |
cellular response to peptide
|
AKR1B1, APP, GPER1, IGF1R, RELA, SRC |
2.64747 |
[BP] GO:0010557 |
positive regulation of macromolecule biosynthetic process
|
APP, AR, AURKB, ESR1, ESR2, ESRRA, ESRRB, GPER1, IGF1R, KDR, MAP2K1, MET, RELA, SRC, TERT |
2.62171 |
[BP] GO:2001234 |
negative regulation of apoptotic signaling pathway
|
AR, BCL2, MMP9, RELA, SRC, TERT |
2.62171 |
[BP] GO:0046110 |
None
|
AOX1, XDH |
2.62171 |
[BP] GO:0032849 |
positive regulation of cellular pH reduction
|
CA2, CA7 |
2.62171 |
[BP] GO:0045597 |
positive regulation of cell differentiation
|
APP, AR, AXL, BCL2, CA2, GPER1, KDR, KIT, MAP2K1, RELA, TERT |
2.61727 |
[BP] GO:0070301 |
cellular response to hydrogen peroxide
|
AKR1B1, AXL, CYP1B1, RELA |
2.61676 |
[BP] GO:0042493 |
response to drug
|
ABCB1, AKR1B1, AXL, BCL2, CA9, CYP1A1, CYP1B1, KDR, RELA, SRC |
2.59921 |
[BP] GO:0001101 |
response to acid chemical
|
AKR1B1, DNMT1, KDR, MMP2, PTGES, RELA, SRC |
2.58655 |
[BP] GO:0048660 |
regulation of smooth muscle cell proliferation
|
AKR1B1, GPER1, MMP2, MMP9, TERT |
2.58209 |
[BP] GO:0019538 |
protein metabolic process
|
ACHE, ALPL, APP, AR, AURKB, AXL, BACE1, BCL2, DYRK1A, ESR1, F3, FLT3, FUT7, IGF1R, KDR, KIT, MAP2K1, MAP3K7, MET, MMP1, MMP2, MMP9, PIM1, RELA, SRC |
2.53775 |
[BP] GO:0048585 |
negative regulation of response to stimulus
|
AR, BCL2, CYP19A1, DYRK1A, ESR1, ESR2, GPER1, IGF1R, MET, MMP9, RELA, SRC, TERT, XDH |
2.53664 |
[BP] GO:1904707 |
positive regulation of vascular smooth muscle cell proliferation
|
MMP2, MMP9, TERT |
2.53664 |
[BP] GO:0030520 |
intracellular estrogen receptor signaling pathway
|
ESR1, ESR2, SRC |
2.53664 |
[BP] GO:1901342 |
regulation of vasculature development
|
CYP1B1, F3, GPER1, KDR, KIT, TERT, XDH |
2.52717 |
[BP] GO:0014068 |
positive regulation of phosphatidylinositol 3-kinase signaling
|
FLT3, GPER1, KDR, KIT |
2.50457 |
[BP] GO:0045935 |
positive regulation of nucleobase-containing compound metabolic process
|
APP, AR, AURKB, DNMT1, ESR1, ESR2, ESRRA, ESRRB, GPER1, IGF1R, MAP2K1, MET, RELA, SRC, TERT |
2.48016 |
[BP] GO:0007568 |
aging
|
AURKB, BCL2, CYP1A1, MAP2K1, RELA, TERT |
2.44811 |
[BP] GO:0051098 |
regulation of binding
|
APP, AURKB, BCL2, MET, MMP9, SRC, TERT |
2.44811 |
[BP] GO:0032870 |
cellular response to hormone stimulus
|
AR, ESR1, FLT3, GPER1, KIT, RELA, SRC |
2.44811 |
[BP] GO:0048878 |
chemical homeostasis
|
AKR1B1, APP, BCL2, CA12, CA2, CA7, CACNA1C, ESR1, FABP4, GPER1, MET |
2.44811 |
[BP] GO:0042180 |
None
|
AKR1B1, AKR1B10, CYP19A1, HSD17B3 |
2.44811 |
[BP] GO:0009653 |
anatomical structure morphogenesis
|
APP, AR, AXL, BCL2, CA2, CA9, CACNA1C, CYP1B1, ESR1, MET, MMP2, RELA, SRC |
2.44811 |
[BP] GO:0019220 |
regulation of phosphate metabolic process
|
APP, AR, BCL2, ESRRB, FABP4, FLT3, GPER1, IGF1R, KDR, KIT, MAP2K1, MAP3K7, MMP9, SRC, XDH |
2.44765 |
[BP] GO:0009892 |
negative regulation of metabolic process
|
APP, AR, AURKB, BCL2, DNMT1, DYRK1A, ESR1, ESR2, ESRRA, FABP4, GPER1, IGF1R, KDR, MAP2K1, MET, MMP9, RELA, SRC, TERT, XDH |
2.44765 |
[BP] GO:0032844 |
regulation of homeostatic process
|
AURKB, BCL2, CA2, CA7, CACNA1C, GPER1, KDR, SRC |
2.43995 |
[BP] GO:0034097 |
response to cytokine
|
AXL, BCL2, FABP4, FLT3, GPER1, PTGES, RELA, SRC |
2.42255 |
[BP] GO:0032268 |
regulation of cellular protein metabolic process
|
APP, AR, BCL2, DNMT1, DYRK1A, ESR1, F3, FABP4, FLT3, GPER1, IGF1R, KDR, KIT, MAP2K1, MAP3K7, MMP9, RELA, SRC, XDH |
2.41663 |
[BP] GO:0051174 |
regulation of phosphorus metabolic process
|
APP, AR, BCL2, ESRRB, FABP4, FLT3, GPER1, IGF1R, KDR, KIT, MAP2K1, MAP3K7, MMP9, SRC, XDH |
2.41656 |
[BP] GO:0006145 |
None
|
AOX1, XDH |
2.38774 |
[BP] GO:0048729 |
tissue morphogenesis
|
AR, BCL2, CA2, CA9, ESR1, MET, SRC |
2.376 |
[BP] GO:0071396 |
cellular response to lipid
|
AR, AXL, ESR1, FLT3, GPER1, RELA, SRC |
2.37017 |
[BP] GO:0071383 |
None
|
AR, FLT3, GPER1, SRC |
2.35405 |
[BP] GO:0022602 |
ovulation cycle process
|
BCL2, ESR1, KIT, SRC |
2.31225 |
[BP] GO:0048661 |
positive regulation of smooth muscle cell proliferation
|
AKR1B1, MMP2, MMP9, TERT |
2.31225 |
[BP] GO:0051897 |
positive regulation of protein kinase B signaling
|
AXL, F3, KIT, MET, SRC |
2.29553 |
[BP] GO:0046427 |
positive regulation of JAK-STAT cascade
|
AKR1B1, CYP1B1, FLT3, KIT |
2.29553 |
[BP] GO:0009891 |
positive regulation of biosynthetic process
|
APP, AR, AURKB, ESR1, ESR2, ESRRA, ESRRB, GPER1, IGF1R, KDR, MAP2K1, MET, RELA, SRC, TERT |
2.27999 |
[BP] GO:0008209 |
androgen metabolic process
|
CYP19A1, ESR1, HSD17B3 |
2.27725 |
[BP] GO:0031960 |
response to corticosteroid
|
ALPL, BCL2, FLT3, GPER1, SRC |
2.26192 |
[BP] GO:0006807 |
nitrogen compound metabolic process
|
ACHE, AKR1B1, AKR1B10, ALPL, AOX1, APP, AR, AURKB, AXL, BACE1, BCL2, CYP1A1, CYP1B1, DNMT1, DYRK1A, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, FUT7, IGF1R, KDR, KIT, MAOA, MAP2K1, MAP3K7, MET, MMP1, MMP2, MMP9, PIM1, RELA, SRC, TERT, XDH |
2.26096 |
[BP] GO:1904894 |
positive regulation of STAT cascade
|
AKR1B1, CYP1B1, FLT3, KIT |
2.26096 |
[BP] GO:0009628 |
response to abiotic stimulus
|
AKR1B1, APP, AURKB, BCL2, CA2, CYP1A1, KIT, MMP2, RELA, SRC, TERT |
2.25803 |
[BP] GO:0050790 |
regulation of catalytic activity
|
APP, AR, AURKB, BCL2, ESR1, F3, FABP4, FLT3, GPER1, IGF1R, KIT, MAP2K1, MAP3K7, MMP9, SRC, TERT, XDH |
2.22147 |
[BP] GO:2001233 |
regulation of apoptotic signaling pathway
|
AR, BCL2, GPER1, MMP9, RELA, SRC, TERT |
2.21207 |
[BP] GO:0002521 |
leukocyte differentiation
|
AXL, BCL2, FLT3, FUT7, KIT, MMP9 |
2.20908 |
[BP] GO:0006367 |
transcription initiation from RNA polymerase II promoter
|
AR, ESR1, ESR2, ESRRA, ESRRB |
2.20908 |
[BP] GO:0061370 |
testosterone biosynthetic process
|
CYP19A1, HSD17B3 |
2.20716 |
[BP] GO:0010641 |
None
|
F3, SRC |
2.20716 |
[BP] GO:0002318 |
myeloid progenitor cell differentiation
|
FLT3, KIT |
2.20716 |
[BP] GO:0043552 |
positive regulation of phosphatidylinositol 3-kinase activity
|
FLT3, KIT, SRC |
2.20716 |
[BP] GO:0043085 |
positive regulation of catalytic activity
|
APP, AURKB, BCL2, ESR1, F3, FLT3, GPER1, KIT, MAP2K1, MAP3K7, SRC, TERT, XDH |
2.17936 |
[BP] GO:0051128 |
regulation of cellular component organization
|
APP, AR, AURKB, AXL, BCL2, DNMT1, ESR1, ESR2, GPER1, IGF1R, KDR, KIT, MAP2K1, MET, MMP1, MMP9, SRC |
2.17081 |
[BP] GO:0048534 |
hematopoietic or lymphoid organ development
|
BCL2, FLT3, KDR, KIT, MAP2K1 |
2.13676 |
[BP] GO:0090218 |
positive regulation of lipid kinase activity
|
FLT3, KIT, SRC |
2.09503 |
[BP] GO:0032496 |
response to lipopolysaccharide
|
ALPL, AXL, CYP1A1, PTGES, RELA, SRC |
2.08946 |
[BP] GO:0008285 |
negative regulation of cell proliferation
|
APP, AR, BCL2, CYP1B1, GPER1, MAP2K1, PTGES, TERT, XDH |
2.08706 |
[BP] GO:0048609 |
multicellular organismal reproductive process
|
AKR1B1, APP, AR, AXL, CYP1A1, ESR1, KIT, SRC |
2.06795 |
[BP] GO:0051902 |
negative regulation of mitochondrial depolarization
|
BCL2, SRC |
2.05879 |
[BP] GO:0046113 |
None
|
AOX1, XDH |
2.05879 |
[BP] GO:0035690 |
cellular response to drug
|
AKR1B1, AXL, CYP1B1, KDR, RELA, SRC |
2.05848 |
[BP] GO:0048511 |
rhythmic process
|
AXL, BCL2, DYRK1A, ESR1, KIT, SRC |
2.04494 |
[BP] GO:1901654 |
None
|
AKR1B1, AR, CA9, RELA, SRC |
2.02958 |
[BP] GO:0031324 |
negative regulation of cellular metabolic process
|
APP, AR, AURKB, BCL2, DNMT1, DYRK1A, ESR1, ESR2, ESRRA, FABP4, GPER1, IGF1R, MET, MMP9, RELA, SRC, TERT, XDH |
2.02244 |
[BP] GO:0045595 |
regulation of cell differentiation
|
APP, AR, AXL, BCL2, CA2, ESRRA, ESRRB, GPER1, KDR, KIT, MAP2K1, RELA, TERT, XDH |
2.02244 |
[BP] GO:0055114 |
oxidation-reduction process
|
AKR1B1, AKR1B10, ALOX5, AOX1, CYP19A1, CYP1A1, CYP1B1, HSD17B3, MAOA, XDH |
2.01646 |
[BP] GO:0051246 |
regulation of protein metabolic process
|
APP, AR, BCL2, DNMT1, DYRK1A, ESR1, F3, FABP4, FLT3, GPER1, IGF1R, KDR, KIT, MAP2K1, MAP3K7, MMP9, RELA, SRC, XDH |
2.01524 |
[BP] GO:0015711 |
organic anion transport
|
ABCB1, CA12, CA14, CA2, CA4, CA7, CA9 |
2.01165 |
[BP] GO:0014911 |
positive regulation of smooth muscle cell migration
|
BCL2, SRC, TERT |
2.00849 |
[CC] GO:0005641 |
nuclear envelope lumen
|
ALOX5, APP, PTGES |
3.68655 |
[CC] GO:0043226 |
organelle
|
ABCB1, ACHE, AKR1B1, AKR1B10, ALPL, AOX1, APP, AR, AURKB, AXL, BACE1, BCL2, CA2, CA4, CA9, CACNA1C, CYP19A1, CYP1A1, CYP1B1, DNMT1, DYRK1A, ESR1, ESR2, ESRRA, ESRRB, F3, FABP4, FLT3, FUT7, GPER1, HSD17B3, IGF1R, KDR, KIT, MAOA, MAP2K1, MAP3K7, MMP2, MMP9, PIM1, RELA, SHBG, SRC, TERT, XDH |
3.21249 |
[CC] GO:0043227 |
membrane-bounded organelle
|
ABCB1, ACHE, AKR1B1, AKR1B10, ALPL, AOX1, APP, AR, AURKB, AXL, BACE1, BCL2, CA2, CA4, CYP19A1, CYP1A1, CYP1B1, DNMT1, DYRK1A, ESR1, ESR2, ESRRA, ESRRB, F3, FABP4, FLT3, FUT7, GPER1, HSD17B3, IGF1R, KDR, KIT, MAOA, MAP2K1, MAP3K7, MMP2, MMP9, PIM1, RELA, SHBG, SRC, TERT, XDH |
3.19533 |
[CC] GO:0005886 |
plasma membrane
|
ABCB1, ACHE, ALPL, APP, AR, AXL, BACE1, CA12, CA14, CA2, CA4, CA9, CACNA1C, ESR1, F3, FLT3, GPER1, IGF1R, KDR, KIT, MAP2K1, MAP3K7, MET, MMP2, PIM1, SRC, TERT |
3.07649 |
[CC] GO:0016020 |
membrane
|
ABCB1, ACHE, ALOX5, ALPL, APP, AR, AXL, BACE1, BCL2, CA12, CA14, CA2, CA4, CA9, CACNA1C, CYP19A1, CYP1A1, CYP1B1, ESR1, F3, FLT3, FUT7, GPER1, HSD17B3, IGF1R, KDR, KIT, MAOA, MAP2K1, MAP3K7, MET, MMP2, PIM1, PTGES, SRC, TERT |
2.53664 |
[CC] GO:0009986 |
cell surface
|
ABCB1, ACHE, APP, AXL, BACE1, CA4, F3, MET |
2.1024 |
[CC] GO:0043231 |
intracellular membrane-bounded organelle
|
ACHE, AKR1B1, AKR1B10, APP, AR, AURKB, BACE1, BCL2, CA4, CYP19A1, CYP1A1, CYP1B1, DNMT1, DYRK1A, ESR1, ESR2, ESRRA, ESRRB, FABP4, FLT3, FUT7, GPER1, HSD17B3, IGF1R, KDR, KIT, MAOA, MAP2K1, MAP3K7, MMP2, PIM1, RELA, SRC, TERT, XDH |
2.06963 |
[MF] GO:0046914 |
transition metal ion binding
|
ALOX5, AOX1, APP, AR, CA12, CA2, CA4, CA7, CA9, CYP19A1, CYP1A1, CYP1B1, DNMT1, ESR1, ESR2, ESRRA, ESRRB, MMP1, MMP2, MMP9, PIM1, XDH |
9.64895 |
[MF] GO:0043167 |
ion binding
|
ABCB1, ACHE, ALOX5, ALPL, AOX1, APP, AR, AURKB, AXL, CA12, CA14, CA2, CA4, CA7, CA9, CACNA1C, CYP19A1, CYP1A1, CYP1B1, DNMT1, DYRK1A, ESR1, ESR2, ESRRA, ESRRB, F3, FABP4, FLT3, IGF1R, KDR, KIT, MAP2K1, MAP3K7, MET, MMP1, MMP2, MMP9, PIM1, PTGES, RELA, SRC, TERT, XDH |
9.28849 |
[MF] GO:0004089 |
carbonate dehydratase activity
|
CA12, CA14, CA2, CA4, CA7, CA9 |
8.12177 |
[MF] GO:0003824 |
catalytic activity
|
ABCB1, ACHE, AKR1B1, AKR1B10, ALOX5, ALPL, AOX1, AURKB, AXL, BACE1, CA12, CA14, CA2, CA4, CA7, CA9, CYP19A1, CYP1A1, CYP1B1, DNMT1, DYRK1A, F3, FLT3, FUT7, HSD17B3, IGF1R, KDR, KIT, MAOA, MAP2K1, MAP3K7, MET, MMP1, MMP2, MMP9, PIM1, PTGES, SRC, TERT, XDH |
7.52438 |
[MF] GO:0004713 |
protein tyrosine kinase activity
|
AXL, DYRK1A, FLT3, IGF1R, KDR, KIT, MAP2K1, MET, SRC |
6.01899 |
[MF] GO:0005496 |
steroid binding
|
AR, ESR1, ESR2, ESRRA, ESRRB, GPER1, SHBG |
5.70547 |
[MF] GO:0098531 |
transcription factor activity, direct ligand regulated sequence-specific DNA binding
|
AR, ESR1, ESR2, ESRRA, ESRRB, GPER1 |
5.65998 |
[MF] GO:0004879 |
nuclear receptor activity
|
AR, ESR1, ESR2, ESRRA, ESRRB, GPER1 |
5.65998 |
[MF] GO:0016836 |
hydro-lyase activity
|
CA12, CA14, CA2, CA4, CA7, CA9 |
5.41563 |
[MF] GO:0003707 |
steroid hormone receptor activity
|
AR, ESR1, ESR2, ESRRA, ESRRB, GPER1 |
5.23788 |
[MF] GO:0004714 |
transmembrane receptor protein tyrosine kinase activity
|
AXL, FLT3, IGF1R, KDR, KIT, MET |
5.14425 |
[MF] GO:0008270 |
zinc ion binding
|
AR, CA12, CA2, CA4, CA7, CA9, DNMT1, ESR1, ESR2, ESRRA, ESRRB, MMP1, MMP2, MMP9 |
5.05248 |
[MF] GO:0043169 |
cation binding
|
ACHE, ALOX5, ALPL, AOX1, APP, AR, AURKB, CA12, CA14, CA2, CA4, CA7, CA9, CACNA1C, CYP19A1, CYP1A1, CYP1B1, DNMT1, ESR1, ESR2, ESRRA, ESRRB, KIT, MAP3K7, MMP1, MMP2, MMP9, PIM1, TERT, XDH |
5.04527 |
[MF] GO:0016835 |
carbon-oxygen lyase activity
|
CA12, CA14, CA2, CA4, CA7, CA9 |
4.74105 |
[MF] GO:0046872 |
metal ion binding
|
ALOX5, ALPL, AOX1, APP, AR, AURKB, CA12, CA14, CA2, CA4, CA7, CA9, CACNA1C, CYP19A1, CYP1A1, CYP1B1, DNMT1, ESR1, ESR2, ESRRA, ESRRB, KIT, MAP3K7, MMP1, MMP2, MMP9, PIM1, TERT, XDH |
4.69586 |
[MF] GO:0019199 |
transmembrane receptor protein kinase activity
|
AXL, FLT3, IGF1R, KDR, KIT, MET |
4.65149 |
[MF] GO:0004672 |
protein kinase activity
|
AURKB, AXL, DYRK1A, FLT3, IGF1R, KDR, KIT, MAP2K1, MAP3K7, MET, PIM1, SRC |
4.44332 |
[MF] GO:0030284 |
estrogen receptor activity
|
ESR1, ESR2, GPER1 |
4.29646 |
[MF] GO:0042802 |
identical protein binding
|
ACHE, AOX1, APP, BCL2, DYRK1A, ESR1, ESR2, FLT3, IGF1R, KDR, KIT, MAP3K7, MET, MMP9, RELA, TERT, XDH |
3.86471 |
[MF] GO:0016773 |
phosphotransferase activity, alcohol group as acceptor
|
AURKB, AXL, DYRK1A, FLT3, IGF1R, KDR, KIT, MAP2K1, MAP3K7, MET, PIM1, SRC |
3.74226 |
[MF] GO:0008144 |
drug binding
|
ABCB1, ACHE, AURKB, AXL, CYP19A1, CYP1A1, CYP1B1, DYRK1A, FLT3, IGF1R, KDR, KIT, MAP2K1, MAP3K7, MET, PIM1, SRC |
3.56324 |
[MF] GO:0016772 |
transferase activity, transferring phosphorus-containing groups
|
AURKB, AXL, DYRK1A, FLT3, IGF1R, KDR, KIT, MAP2K1, MAP3K7, MET, PIM1, SRC, TERT |
3.4585 |
[MF] GO:0016301 |
kinase activity
|
AURKB, AXL, DYRK1A, FLT3, IGF1R, KDR, KIT, MAP2K1, MAP3K7, MET, PIM1, SRC |
3.43151 |
[MF] GO:0042562 |
hormone binding
|
ACHE, AR, GPER1, IGF1R, SHBG |
3.29191 |
[MF] GO:0005506 |
iron ion binding
|
ALOX5, AOX1, CYP19A1, CYP1A1, CYP1B1, XDH |
3.18302 |
[MF] GO:0016903 |
None
|
AKR1B1, AKR1B10, AOX1, XDH |
3.07649 |
[MF] GO:0038052 |
RNA polymerase II transcription factor activity, estrogen-activated sequence-specific DNA binding
|
ESR1, ESR2 |
3.01168 |
[MF] GO:0016829 |
lyase activity
|
CA12, CA14, CA2, CA4, CA7, CA9 |
2.89784 |
[MF] GO:0008289 |
lipid binding
|
AR, AXL, ESR1, ESR2, ESRRA, ESRRB, F3, FABP4, GPER1, SHBG |
2.86631 |
[MF] GO:0043168 |
anion binding
|
ABCB1, AOX1, APP, AURKB, AXL, DYRK1A, F3, FABP4, FLT3, IGF1R, KDR, KIT, MAP2K1, MAP3K7, MET, PIM1, PTGES, RELA, SRC, XDH |
2.82422 |
[MF] GO:0016491 |
oxidoreductase activity
|
AKR1B1, AKR1B10, ALOX5, AOX1, CYP19A1, CYP1A1, CYP1B1, HSD17B3, MAOA, XDH |
2.62171 |
[MF] GO:0008134 |
transcription factor binding
|
AR, BCL2, ESR1, ESRRB, FLT3, PIM1, RELA, SRC, TERT |
2.56874 |
[MF] GO:0004871 |
signal transducer activity
|
AR, AXL, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, GPER1, IGF1R, KDR, KIT, MAP2K1, MAP3K7, MET |
2.50359 |
[MF] GO:0070330 |
aromatase activity
|
CYP19A1, CYP1A1, CYP1B1 |
2.48564 |
[MF] GO:0016614 |
oxidoreductase activity, acting on CH-OH group of donors
|
AKR1B1, AKR1B10, AOX1, HSD17B3, XDH |
2.48016 |
[MF] GO:0034056 |
estrogen response element binding
|
ESR1, ESR2 |
2.38774 |
[MF] GO:0005497 |
None
|
AR, SHBG |
2.38774 |
[MF] GO:0016712 |
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen
|
CYP19A1, CYP1A1, CYP1B1 |
2.36105 |
[MF] GO:0038023 |
signaling receptor activity
|
AR, AXL, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, GPER1, IGF1R, KDR, KIT, MET |
2.30185 |
[MF] GO:0000166 |
nucleotide binding
|
ABCB1, AOX1, AURKB, AXL, DNMT1, DYRK1A, FLT3, IGF1R, KDR, KIT, MAP2K1, MAP3K7, MET, PIM1, SRC, XDH |
2.14747 |
[MF] GO:1901265 |
nucleoside phosphate binding
|
ABCB1, AOX1, AURKB, AXL, DNMT1, DYRK1A, FLT3, IGF1R, KDR, KIT, MAP2K1, MAP3K7, MET, PIM1, SRC, XDH |
2.14671 |
[MF] GO:0140096 |
catalytic activity, acting on a protein
|
AURKB, AXL, BACE1, DYRK1A, F3, FLT3, IGF1R, KDR, KIT, MAP2K1, MAP3K7, MET, MMP1, MMP2, MMP9, PIM1, SRC |
2.1024 |
[MF] GO:0043546 |
None
|
AOX1, XDH |
2.05879 |
[MF] GO:0005524 |
ATP binding
|
ABCB1, AURKB, AXL, DYRK1A, FLT3, IGF1R, KDR, KIT, MAP2K1, MAP3K7, MET, PIM1, SRC |
2.04783 |